The performance of interferon gamma release assays in patients with nontuberculous mycobacterial infection: a systematic review and meta-analysis

[21] Yao X(2011)Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay Int J Tuberc Lung Dis 15 635-1307

[22] Xu Y(2014)Interferon-gamma enzyme-linked immunospot assay in patients with tuberculosis and healthy adults Tuberc Respir Dis (Seoul) 76 23-540

[23] Li T(2019)Isolation measures and protection awareness are significant for latent tuberculosis infection: a cross-sectional study based on T-SPOT.TB among health care workers in China Epidemiol Infect 147 e120-315

[24] Su B(2012)Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis Plos One 7 e32482-165

[25] Chen Z(2019)Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-gamma release assays: A systematic review and meta-analysis Adv Med Sci 64 437-223

[26] Ma R(2019)Risk factors for false-negative interferon-gamma release assay results in culture-confirmed childhood TB Am J Trop Med Hyg 101 1303-443

[27] Jiang Y(2018)Characteristics associated with negative interferon-gamma release assay results in culture-confirmed tuberculosis patients, Texas, USA, 2013–2015 Emerg Infect Dis 24 534-111

[28] Ma X(2017)Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review Diagn Microbiol Infect Dis 88 308-undefined

[29] Bi D(2018)Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection Clin Microbiol Infect 24 159-undefined

[30] Ma J(2020)A global update on rare non-tuberculous mycobacteria in humans: epidemiology and emergence Int J Tuberc Lung Dis 24 214-undefined

[21] Yao X(2011)Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay Int J Tuberc Lung Dis 15 635-1307

[22] Xu Y(2014)Interferon-gamma enzyme-linked immunospot assay in patients with tuberculosis and healthy adults Tuberc Respir Dis (Seoul) 76 23-540

[23] Li T(2019)Isolation measures and protection awareness are significant for latent tuberculosis infection: a cross-sectional study based on T-SPOT.TB among health care workers in China Epidemiol Infect 147 e120-315

[24] Su B(2012)Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis Plos One 7 e32482-165

[25] Chen Z(2019)Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-gamma release assays: A systematic review and meta-analysis Adv Med Sci 64 437-223

[26] Ma R(2019)Risk factors for false-negative interferon-gamma release assay results in culture-confirmed childhood TB Am J Trop Med Hyg 101 1303-443

[27] Jiang Y(2018)Characteristics associated with negative interferon-gamma release assay results in culture-confirmed tuberculosis patients, Texas, USA, 2013–2015 Emerg Infect Dis 24 534-111

[28] Ma X(2017)Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review Diagn Microbiol Infect Dis 88 308-undefined

[29] Bi D(2018)Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection Clin Microbiol Infect 24 159-undefined

[30] Ma J(2020)A global update on rare non-tuberculous mycobacteria in humans: epidemiology and emergence Int J Tuberc Lung Dis 24 214-undefined